These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 34255498)

  • 21. Detection of human butyrylcholinesterase-nerve gas adducts by liquid chromatography-mass spectrometric analysis after in gel chymotryptic digestion.
    Tsuge K; Seto Y
    J Chromatogr B Analyt Technol Biomed Life Sci; 2006 Jun; 838(1):21-30. PubMed ID: 16569519
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Identification of novel disulfide adducts between the thiol containing leaving group of the nerve agent VX and cysteine containing tripeptides derived from human serum albumin.
    Kranawetvogl A; Küppers J; Gütschow M; Worek F; Thiermann H; Elsinghorst PW; John H
    Drug Test Anal; 2017 Aug; 9(8):1192-1203. PubMed ID: 27935238
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Matrix-assisted laser desorption/ionization time-of-flight mass spectrometry of titanium oxide-enriched peptides for detection of aged organophosphorus adducts on human butyrylcholinesterase.
    Jiang W; Murashko EA; Dubrovskii YA; Podolskaya EP; Babakov VN; Mikler J; Nachon F; Masson P; Schopfer LM; Lockridge O
    Anal Biochem; 2013 Aug; 439(2):132-41. PubMed ID: 23624322
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Comparison of Efficiency of Purification (from Human Plasma) of a Nerve Agent Adduct of Butyrylcholinesterase Between the Affinity Gel Method and Immunomagnetic Separation.
    Lee JY
    J Chromatogr Sci; 2018 Mar; 56(3):248-253. PubMed ID: 29244127
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Simultaneous quantification of soman and VX adducts to butyrylcholinesterase, their aged methylphosphonic acid adduct and butyrylcholinesterase in plasma using an off-column procainamide-gel separation method combined with UHPLC-MS/MS.
    Liu CC; Huang GL; Xi HL; Liu SL; Liu JQ; Yu HL; Zhou SK; Liang LH; Yuan L
    J Chromatogr B Analyt Technol Biomed Life Sci; 2016 Nov; 1036-1037():57-65. PubMed ID: 27718463
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Precisely predicting the
    Jeong K; Ryu TI; Hwang SR; Cho Y; Lim KC; Yoon UH; Lee JY; Yoon YW; Jeong HJ
    Sci Rep; 2022 Nov; 12(1):20288. PubMed ID: 36434133
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Release of protein-bound nerve agents by excess fluoride from whole blood: GC-MS/MS method development, validation, and application to a real-life denatured blood sample.
    Koller M; Thiermann H; Worek F; Wille T
    J Chromatogr B Analyt Technol Biomed Life Sci; 2021 Aug; 1179():122693. PubMed ID: 34171608
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Quantification of nerve agent VX-butyrylcholinesterase adduct biomarker from an accidental exposure.
    Solano MI; Thomas JD; Taylor JT; McGuire JM; Jakubowski EM; Thomson SA; Maggio VL; Holland KE; Smith JR; Capacio B; Woolfitt AR; Ashley DL; Barr JR
    J Anal Toxicol; 2008; 32(1):68-72. PubMed ID: 18269796
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Identification of 2-(diethylamino)ethylthiol dipeptide (Cys-Pro) adduct as biomarker of nerve agents VR and CVX in human plasma using liquid chromatography-high-resolution tandem mass spectrometry.
    Baygildiev ТМ; Vokuev MF; Braun AV; Yashkir VA; Rуbalchenko IV; Rodin IA
    Anal Bioanal Chem; 2021 Mar; 413(7):1905-1916. PubMed ID: 33479815
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Advice on assistance and protection provided by the Scientific Advisory Board of the Organisation for the Prohibition of Chemical Weapons: Part 1. On medical care and treatment of injuries from nerve agents.
    Timperley CM; Forman JE; Abdollahi M; Al-Amri AS; Baulig A; Benachour D; Borrett V; Cariño FA; Geist M; Gonzalez D; Kane W; Kovarik Z; Martínez-Álvarez R; Mourão NMF; Neffe S; Raza SK; Rubaylo V; Suárez AG; Takeuchi K; Tang C; Trifirò F; van Straten FM; Vanninen PS; Vučinić S; Zaitsev V; Zafar-Uz-Zaman M; Zina MS; Holen S
    Toxicology; 2019 Mar; 415():56-69. PubMed ID: 30639304
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Online coupling of immunoextraction, digestion, and microliquid chromatography-tandem mass spectrometry for the analysis of sarin and soman-butyrylcholinesterase adducts in human plasma.
    Bonichon M; Valbi V; Combès A; Desoubries C; Bossée A; Pichon V
    Anal Bioanal Chem; 2018 Jan; 410(3):1039-1051. PubMed ID: 28971225
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Bioanalytical verification of V-type nerve agent exposure: simultaneous detection of phosphonylated tyrosines and cysteine-containing disulfide-adducts derived from human albumin.
    Kranawetvogl A; Küppers J; Siegert M; Gütschow M; Worek F; Thiermann H; Elsinghorst PW; John H
    Anal Bioanal Chem; 2018 Feb; 410(5):1463-1474. PubMed ID: 29322229
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Selective Colorimetric Detection of Novichok Agents with Hydrazone Chemosensors.
    Termeau L; Penlou S; Carella A
    ACS Sens; 2023 Apr; 8(4):1510-1517. PubMed ID: 37036422
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Novichok agents: a historical, current, and toxicological perspective.
    Chai PR; Hayes BD; Erickson TB; Boyer EW
    Toxicol Commun; 2018; 2(1):45-48. PubMed ID: 30003185
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Simultaneous Time-concentration Analysis of Soman and VX Adducts to Butyrylcholinesterase and Albumin by LC-MS-MS.
    Lee JY; Kim C; Lee YH
    J Anal Toxicol; 2018 Jun; 42(5):293-299. PubMed ID: 29618078
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Modifications to the organophosphorus nerve agent-protein adduct refluoridation method for retrospective analysis of nerve agent exposures.
    Holland KE; Solano MI; Johnson RC; Maggio VL; Barr JR
    J Anal Toxicol; 2008; 32(1):116-24. PubMed ID: 18269803
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Advice on assistance and protection from the Scientific Advisory Board of the Organisation for the Prohibition of Chemical Weapons: Part 2. On preventing and treating health effects from acute, prolonged, and repeated nerve agent exposure, and the identification of medical countermeasures able to reduce or eliminate the longer term health effects of nerve agents.
    Timperley CM; Abdollahi M; Al-Amri AS; Baulig A; Benachour D; Borrett V; Cariño FA; Geist M; Gonzalez D; Kane W; Kovarik Z; Martínez-Álvarez R; Fusaro Mourão NM; Neffe S; Raza SK; Rubaylo V; Suárez AG; Takeuchi K; Tang C; Trifirò F; van Straten FM; Vanninen PS; Vučinić S; Zaitsev V; Zafar-Uz-Zaman M; Zina MS; Holen S; Forman JE; Alwan WS; Suri V
    Toxicology; 2019 Feb; 413():13-23. PubMed ID: 30500381
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Immunomagnetic separation and quantification of butyrylcholinesterase nerve agent adducts in human serum.
    Sporty JL; Lemire SW; Jakubowski EM; Renner JA; Evans RA; Williams RF; Schmidt JG; van der Schans MJ; Noort D; Johnson RC
    Anal Chem; 2010 Aug; 82(15):6593-600. PubMed ID: 20617824
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Characterization and Study on Fragmentation Pathways of a Novel Nerve Agent, 'Novichok (A234)', in Aqueous Solution by Liquid Chromatography-Tandem Mass Spectrometry.
    Lee JY; Lim KC; Kim HS
    Molecules; 2021 Feb; 26(4):. PubMed ID: 33670472
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Optimized verification method for detection of an albumin-sulfur mustard adduct at Cys(34) using a hybrid quadrupole time-of-flight tandem mass spectrometer after direct plasma proteolysis.
    John H; Siegert M; Gandor F; Gawlik M; Kranawetvogl A; Karaghiosoff K; Thiermann H
    Toxicol Lett; 2016 Feb; 244():103-111. PubMed ID: 26449527
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.